title: Gut microbiome predictors of treatment response and recurrence in primary Clostridium difficile infection
design: Pre-treatment stool samples and clinical metadata including outcomes were collected prospectively from patients with their first CDI episode. Next generation 16s rRNA sequencing using MiSeq Illumina platform was performed (targeting V4 region) and changes in microbial community structure were correlated with CDI outcomes.